Enanta Pharmaceuticals Inc. logo

Enanta Pharmaceuticals Inc.

ENTA | NASDAQ
Chart Builder DCF Calculator
$12.11
-$0.09 (-0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$12.11
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$352.14M
Enterprise Value
$218.29M
Beta
0.94
Average Volume
216.7K
Shares Outstanding (Diluted)
29.09M
Shares Change YoY
36.43%
Institutional Ownership
92.19%
Exchange
NASDAQ
ISIN
US29251M1062

Price Performance

Price Change 1M
-8.7%
Price Change 3M
-13.9%
Price Change 6M
-0.5%
Price Change YTD
-16.0%
Price Change 1Y
57.3%
Price Change 3Y
1.9%
Price Change 5Y
-78.4%
1M CAGR (ann.)
-12.1%
1Y CAGR (ann.)
54.5%
5Y CAGR (ann.)
-26.7%
All-Time CAGR
-2.5%

Valuation

PE Ratio
-4.75
Forward PE
N/A
PEG Ratio
-0.08
Forward PEG
0.57
PS Ratio
5.40
Forward PS
5.50
PB Ratio
3.48
P/FCF Ratio
-9.53
P/Adj. FCF Ratio
-6.74
P/OCF Ratio
-10.01
EV/Sales
3.35
EV/EBIT
-4.35
EV/EBITDA
-4.70
EV/FCF
-5.91
Earnings Yield
-21.1%
FCF Yield
-10.5%
Adj. FCF Yield
-14.8%

Financial Health

Net Cash
$133.85M
Total Debt
$55.66M
Cash & Short-Term Investments
$189.51M
Total Assets
$296.87M
Current Ratio
3.76
Quick Ratio
3.76
Debt / Equity Ratio
0.55
Debt / EBITDA
-1.20
Debt / FCF
-1.51
OCF / Debt
-0.63
Interest Coverage
-4.55
Altman Z-Score
-0.77
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
98.2%
Operating Profit Margin
-90.0%
EBITDA Margin
-71.2%
Net Profit Margin
-96.9%
FCF Margin
-56.6%
Adj. FCF Margin
-80.0%
SBC / Revenue
23.4%
SBC Impact (per share)
-41.3%

Returns

Return on Assets
-21.3%
Return on Equity
-61.8%
Return on Invested Capital
-23.8%
Return on Capital Employed
-24.2%
Return on Tangible Assets
-21.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
-6.8%
Revenue CAGR 5Y
-7.7%
Revenue CAGR 10Y
-3.1%
EPS CAGR 3Y
35.3%
EPS CAGR 5Y
17.6%
EPS CAGR 10Y
-36.4%
FCF CAGR 3Y
52.6%
FCF CAGR 5Y
22.6%
FCF CAGR 10Y
-49.5%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
19
EPS Growth Next 3Y
6.3%
Revenue Growth Next 3Y
14.0%
Earnings Date
Nov 15, 2026
EPS Estimate (next Q)
-$0.77
EPS Growth Est (next Q)
-11.5%
Revenue Est (next Q)
$15.7M
Revenue Growth Est (next Q)
3.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$20
Price Target Upside
65.2%

Cash Flow

Operating Cash Flow
$-35.32M
Free Cash Flow
$-36.94M
Adj. Free Cash Flow
$-52.21M
FCF Per Share
-$1.27
OCF Per Share
-$1.21
OCF/S Ratio
-54.1%

Income Statement

Revenue
$65.26M
Gross Profit
$64.05M
Operating Income
$-58.73M
EBITDA
$-46.49M
Net Income
$-63.23M
EPS (Diluted)
-$2.55
Revenue / Employee
$543.82K
Profit / Employee
$-526.92K
Employees
120

© 2026 bestshares.com. All rights reserved.